MedImmune LLC赞助的临床试验
总计10790个结果
-
Adimmune Corporation完全的
-
Ludwig Institute for Cancer ResearchCelgene; Cancer Research Institute, New York City; MedImmune LLC完全的
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); AstraZeneca; Juno Therapeutics, Inc.; MedImmune LLC终止复发性弥漫性大 B 细胞淋巴瘤 | 复发性原发性纵隔(胸腺)大 B 细胞淋巴瘤 | 难治性弥漫性大 B 细胞淋巴瘤 | 难治性原发性纵隔(胸腺)大 B 细胞淋巴瘤 | 具有 MYC、BCL2 和 BCL6 重排的难治性高级 B 细胞淋巴瘤 | 弥漫性大 B 细胞淋巴瘤,未另行说明美国
-
Adimmune Corporation完全的
-
Royal Marsden NHS Foundation TrustEli Lilly and Company; AstraZeneca; Clovis Oncology, Inc.; MedImmune LLC招聘中
-
Ludwig Institute for Cancer ResearchCancer Research Institute, New York City; MedImmune LLC; Targovax ASA完全的
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's Hospital; MedImmune LLC完全的
-
Angle plcMidLantic Urology, LLC终止
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH); MedImmune LLC终止三阴性乳腺癌 | 三阴性乳腺肿瘤 | TNBC - 三阴性乳腺癌 | 三阴性乳腺癌美国
-
Ludwig Institute for Cancer ResearchBoehringer Ingelheim; MedImmune LLC; PharmaJet, Inc.; CureVac; Cancer Research Institute (CRI)完全的
-
RevimmuneAmarex Clinical Research终止
-
Ludwig Institute for Cancer ResearchCancer Research Institute, New York City; MedImmune LLC; Multiple Myeloma Research Foundation终止
-
LLS PedAL Initiative, LLCKura Oncology尚未招聘复发/难治性 KMT2A-r 急性白血病 | 复发/难治性 NUP98-r 急性白血病 | 复发/难治性 NPM1-m 急性白血病
-
Verily Life Sciences LLCThe Emmes Company, LLC; Optos, PLC; Google LLC.; Nikon Corporation完全的
-
Providence Health & ServicesMedImmune LLC; Providence Cancer Center, Earle A. Chiles Research Institute; Robert W. Franz Cancer...完全的
-
Ludwig Institute for Cancer ResearchCancer Research Institute, New York City; MedImmune LLC; Cure Brain Cancer Foundation, Australia完全的
-
MedRegen LLCJohns Hopkins University; ICON plc招聘中
-
Redx Pharma PlcMerck Sharp & Dohme LLC完全的
-
4D pharma plcMerck Sharp & Dohme LLC终止
-
IVFarma LLCBridgePharm LLC; GlobalPharma LLC完全的
-
MedImmune LLCNational Institute of Allergy and Infectious Diseases (NIAID); Innovative Medicines Initiative... 和其他合作者完全的
-
MedImmune LLCNational Institute of Allergy and Infectious Diseases (NIAID); Antibacterial Resistance Leadership... 和其他合作者完全的铜绿假单胞菌西班牙, 美国, 比利时, 法国, 匈牙利, 英国, 以色列, 奥地利, 葡萄牙, 希腊, 捷克语, 火鸡, 克罗地亚, 爱尔兰
-
Pharmtechnology LLCClinPharmInvest, LLC完全的
-
Pharmtechnology LLCClinPharmInvest, LLC完全的
-
Pharmtechnology LLCClinPharmInvest, LLC完全的
-
RevimmuneWashington University School of Medicine终止